Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology
Free Medical Books

  Malignant Lymphoma

  Free Subscription


30.01.2012

1 Am J Clin Pathol
1 Am J Pathol
4 Blood
1 Br J Dermatol
2 Br J Haematol
1 Dtsch Med Wochenschr
3 Haematologica
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
2 J Clin Oncol
1 J Immunol
8 Leuk Lymphoma
1 Oncogene


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Pathol

  1. ERBER WN , Finlayson J
    Hematologic features of hepatosplenic T-cell lymphoma.
    Am J Clin Pathol. 2012;137:334-5.
    PubMed     Text format     Related articles   



    Am J Pathol

  2. JI M , Rao E, Ramachandrareddy H, Shen Y, et al
    The miR-17-92 microRNA cluster is regulated by multiple mechanisms in B-cell malignancies.
    Am J Pathol. 2011;179:1645-56.
    PubMed     Text format     Related articles    Abstract available



    Blood

  3. DI SABATINO A , Biagi F, Gobbi PG, Corazza GR, et al
    How I treat enteropathy-associated T-cell lymphoma.
    Blood. 2012.
    PubMed     Text format     Related articles    Abstract available


  4. GUPTA P , Goldenberg DM, Rossi EA, Cardillo TM, et al
    Dual-targeting immunotherapy of lymphoma: potent cytotoxicity of anti-CD20/CD74 bispecific antibodies in mantle cell and other lymphomas.
    Blood. 2012.
    PubMed     Text format     Related articles    Abstract available



  5. RETRACTION: Xin Huang, Kushi Kushekhar, Ilja Nolte, Wierd Kooistra, Lydia Visser, Ilby Bouwman, Niels Kouprie, Rianne Veenstra, Gustaaf van Imhoff, Bianca Olver, Richard S. Houlston, Sibrand Poppema, Arjan Diepstra, Bouke Hepkema and Anke van den Berg
    Blood. 2012.
    PubMed     Text format     Related articles   


  6. LUPOV IP , Voiles L, Han L, Schwartz A, et al
    Acquired STAT4 deficiency as a consequence of cancer chemotherapy.
    Blood. 2011;118:6097-106.
    PubMed     Text format     Related articles    Abstract available



    Br J Dermatol

  7. TENNIS P , Gelfand JM, Rothman KJ
    Evaluation of Cancer Risk Related to Atopic Dermatitis and Use of Topical Calcineurin Inhibitors.
    Br J Dermatol. 2011 Apr 5. doi: 10.1111/j.1365-2133.2011.10363.
    PubMed     Text format     Related articles    Abstract available



    Br J Haematol

  8. MILES RR , Arnold S, Cairo MS
    Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.
    Br J Haematol. 2012 Jan 20. doi: 10.1111/j.1365-2141.2011.09024.
    PubMed     Text format     Related articles    Abstract available


  9. MAGRATH I
    Epidemiology: clues to the pathogenesis of Burkitt lymphoma.
    Br J Haematol. 2012 Jan 20. doi: 10.1111/j.1365-2141.2011.09013.
    PubMed     Text format     Related articles    Abstract available



    Dtsch Med Wochenschr

  10. KAHL C , Jost K, Knauerhase A, Leithauser M, et al
    [Recurrent hypoglycemia and a large intraabdominal tumor in a 61-year-old woman].
    Dtsch Med Wochenschr. 2011;136:2542-6.
    PubMed     Text format     Related articles    Abstract available



    Haematologica

  11. PERSKY DO , Dornan D, Goldman B, Braziel R, et al
    Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone.
    Haematologica. 2012.
    PubMed     Text format     Related articles    Abstract available


  12. DEVILLIER R , Coso D, Castagna L, Brenot Rossi I, et al
    Positron emission tomography response at time of autologous stem cell transplantation predict outcome of patients with relapsed and/or refractory Hodgkin Lymphoma responding to prior salvage therapy.
    Haematologica. 2012.
    PubMed     Text format     Related articles    Abstract available


  13. UDDIN S , Hussain AR, Ahmed M, Siddiqui K, et al
    Over-expression of FoxM1 offers a promising therapeutic target in diffuse large B-cell lymphoma.
    Haematologica. 2012.
    PubMed     Text format     Related articles    Abstract available



    Int J Cancer

  14. BECKER N , Falster MO, Vajdic CM, de Sanjose S, et al
    Self-reported history of infections and the risk of non-Hodgkin lymphoma: An InterLymph pooled analysis.
    Int J Cancer. 2012 Jan 21. doi: 10.1002/ijc.27438.
    PubMed     Text format     Related articles    Abstract available



    Int J Radiat Oncol Biol Phys

  15. MARALDO MV , Brodin NP, Vogelius IR, Aznar MC, et al
    Risk of Developing Cardiovascular Disease after Involved Node Radiotherapy versus Mantle Field for Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



    J Clin Oncol

  16. VON TRESCKOW B , Plutschow A, Fuchs M, Klimm B, et al
    Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial.
    J Clin Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available


  17. COIFFIER B , Pro B, Prince HM, Foss F, et al
    Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy.
    J Clin Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available



    J Immunol

  18. MCPHEE CG , Sproule TJ, Shin DM, Bubier JA, et al
    MHC Class I Family Proteins Retard Systemic Lupus Erythematosus Autoimmunity and B Cell Lymphomagenesis.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available



    Leuk Lymphoma

  19. KIM SJ , Moon JH, Kim H, Kim JS, et al
    Non-bacterial infections in Asian patients treated with alemtuzumab: A retrospective study of the Asian Lymphoma Study Group.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available


  20. KIM JH , Kim WS, Park C
    Epstein-Barr virus LMP1 protect B cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available


  21. ELSTROM RL , Andemariam B, Martin P, Ruan J, et al
    Bortezomib in combination with R-DICE chemoimmunotherapy (VIPER) in patients with relapsed and primary refractory diffuse large B cell lymphoma.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available


  22. CABRERA ME , Martinez V, Nathwani BN, Konrad Muller-Hermelink H, et al
    Non-Hodgkin lymphoma in Chile. A review of 207 consecutive adult cases by a panel of five expert hematopathologists.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available


  23. PROCHAZKA V , Faber E, Raida L, Langova K, et al
    High baseline serum thymidine kinase 1 level predicts unfavorable outcome in patients with follicular lymphoma.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available


  24. THOENNISSEN NH , Thoennissen GB, Abbassi S, Nabavi-Nouis S, et al
    The transcription factor C/EBPalpha and critical circadian clock downstream target gene, PER2, are highly deregulated in diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available


  25. HUNTINGTON SF , Talbott MS, Greer JP, Morgan DS, et al
    Toxicities and Outcomes among Septuagenarians and Octogenarians with Diffuse Large B cell Lymphoma Treated with Rituximab-CHOP Therapy.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles    Abstract available


  26. CAJAIBA MM , Kahwash SB
    Interfollicular Hodgkin Lymphoma in Children: an Uncommon Mimicker of Reactive Lymphadenopathy.
    Leuk Lymphoma. 2012.
    PubMed     Text format     Related articles   



    Oncogene

  27. CARPENTER EL , Haglund EA, Mace EM, Deng D, et al
    Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma.
    Oncogene. 2012 Jan 23. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: